Research Paper Volume 14, Issue 23 pp 9617—9631
A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
Figure 9. The impact of the newly-established signature on immunotherapy. (A) PD-L1 was overexpressed in the high-risk cohort than its counterpart. (B) Bar plot showed MSI-H had a larger fraction in the high-risk cohort than its counterpart. (C) Box plot showed that the high-risk cohort had an elevated MSI compared to its counterpart. (D) Scatter plot demonstrated that MSI was critically associated with risk scores.